The risk of relapse after anti-TNF discontinuation in inflammatory bowel disease: systematic review and meta-analysis

JP Gisbert, AC Marin, M Chaparro - Official journal of the …, 2016 - journals.lww.com
OBJECTIVES: To perform a meta-analysis of the risk of relapse after discontinuation of anti-
tumor necrosis factor (anti-TNF) therapy in patients with Crohn's disease (CD) and ulcerative …

Methotrexate for maintenance of remission in Crohn's disease

V Patel, Y Wang, JK MacDonald… - Cochrane Database …, 2014 - cochranelibrary.com
Background Safe and effective long‐term treatments that reduce the need for corticosteroids
are needed for Crohn's disease. Although purine antimetabolites are moderately effective for …

[HTML][HTML] Five-year efficacy and safety of ustekinumab treatment in Crohn's disease: the IM-UNITI trial

WJ Sandborn, R Rebuck, Y Wang, B Zou… - Clinical …, 2022 - Elsevier
Background & Aims The IM-UNITI study and long-term extension (LTE) evaluated the long-
term efficacy, safety, and immunogenicity of subcutaneous ustekinumab maintenance …

Drosophotoxicology: the growing potential for Drosophila in neurotoxicology

MD Rand - Neurotoxicology and teratology, 2010 - Elsevier
Understanding neurotoxic mechanisms is a challenge of deciphering which genes and gene
products in the developing or mature nervous system are targeted for disruption by …

Methotrexate for induction of remission in refractory Crohn's disease

JWD McDonald, Y Wang, DJ Tsoulis… - Cochrane database …, 2014 - cochranelibrary.com
Background Although corticosteroids are effective for induction of remission of Crohn's
disease, many patients relapse when steroids are withdrawn or become steroid dependent …

Use of methotrexate in the treatment of inflammatory bowel diseases

HH Herfarth, MD Kappelman, MD Long… - Inflammatory bowel …, 2016 - academic.oup.com
Low-dose methotrexate (MTX) therapy is a well-recognized therapy for many inflammatory
conditions such as rheumatoid arthritis, psoriatic arthritis, and psoriasis. More than 20 years …

[HTML][HTML] Epidemiology and clinical course of Crohn's disease: results from observational studies

Ø Hovde, BA Moum - World journal of gastroenterology: WJG, 2012 - ncbi.nlm.nih.gov
The authors review the clinical outcome in patients with Crohn's disease (CD) based on
studies describing the natural course of the disease. Population-based studies have …

malignancy on thiopurine treatment with special reference to inflammatory bowel disease

MA Smith, PM Irving, AM Marinaki… - Alimentary …, 2010 - Wiley Online Library
Aliment Pharmacol Ther 2010; 32: 119–130 Summary Background Immunosuppression is a
risk factor for carcinogenesis. Thiopurines specifically contribute to this. As thiopurines are …

Drug repositioning in the treatment of malaria and TB

A Nzila, Z Ma, K Chibale - Future medicinal chemistry, 2011 - Future Science
The emergence and spread of drug resistance in the malaria parasite Plasmodium
falciparum as well as multi-and extremely drug-resistant forms of Mycobacterium …

Efficacy and safety of methotrexate in the management of inflammatory bowel disease: a systematic review and meta-analysis of randomized, controlled trials

OH Nielsen, C Steenholdt, CB Juhl, G Rogler - EClinicalMedicine, 2020 - thelancet.com
Background The therapeutic role of methotrexate (MTX) for management of inflammatory
bowel disease (IBD) remains unclear. Methods We systematically reviewed randomized …